Probiotics for the treatment of antibiotic-associated diarrhea in children
Journal Title: Здоров`я дитини - Year 2019, Vol 14, Issue 6
Abstract
Antibiotic-associated diarrhea (AAD) is considered to be one of the most common complications of antibiotic therapy at the outpatient and inpatient stages of treatment in children. The major risk factors for the development of AAD are impaired colonization resistance of the intestinal microflora or direct mucosal irritation with the antibiotics (AB). Severe forms of AAD, known as pseudomembranous colitis, have been associated with Clostridium difficile infection (CDI), which is one of the leading causes in the structure of nosocomial and community-acquired infections and is characterized by considerable resistance to drug treatment. Alternative treatment strategies have been investigated, namely the possibility of adjuvant probiotic therapy, which may contribute to the normalization of indigenous microbiota impaired by AB and be appropriate for the prevention of AAD and CDI development. A review of the literature on the evaluation of the clinical efficacy of the prevention and treatment of AAD and CDI by probiotic drugs and certain probiotic strains was conducted. The literature was searched using electronic databases (Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, CyberLeninka, RINC). The general characteristics of probiotic preparations are presented, the mechanisms of probiotic action are considered, and the bases of the effects of probiotic strains are analyzed. Data from randomized controlled trials have been systematized and analyzed; evidence of the effectiveness of AAD and CDI prevention and treatment by using probiotics is presented. The specific effects of probiotics on the prevention and treatment of AAD and CDI in children have been analyzed. The individual properties of the probiotic strain Lactobacillus rhamnosus GG are considered. The comparative characteristics of the evidence base of using probiotics in certain clinical situations are presented. Recommendations have been given to evaluate the possibility of using probiotic strains and to select a specific probiotic strain for the prevention and treatment of AAD and CDI in children receiving antibiotics.
Authors and Affiliations
N. Yu Zavhorodnia, L. L. Petrenko
Keywords
Related Articles
- EP ID EP667014
- DOI 10.22141/2224-0551.14.6.2019.179246
- Views 90
- Downloads 0
Peculiarities of the Early Neonatal and Postnatal Diagnosis, Clinical Picture, Treatment and Prognosis of Tricuspid Atresia
The article presents the published data on the prevalence, the main clinical manifestations, modern methods of early neonatal and postnatal diagnosis, treatment and prognosis of tricuspid atresia — the congenital malform...
Present and future etiological treatment of bacterial pneumonia 2. Antibiotic therapy of hospital-acquired pneumonia
The choice of antibacterial drugs in the treatment of nosocomial pneumonia is a fairly complex clinical task that clearly depends on the etiology of the disease. According to the general guidelines of ATS/IDSA for antiba...
Degree of Disorders of Calcium-Phosphorus Maintenance in Children with Food Allergy Signs Depending on Allergic Inflammation Activity
37 % of children aged from 1 to 3 years old have impairment in various parameters associated with food allergy. These changes are typical for osteogenesis (reduced concentration of general calcium by 15.7 %, non-organic...
Risk Factor for H.Pylori Infection in Children
Background. The aim of this study was determine the prognostic value of medical, biological and socio-hygienic factors in the formation of H.pylori infection in children. Methods. 283 children aged 7 to 17 years with chr...
Metabolic Syndrome in Children: Clinical Picture, Features of Lipid and Carbohydrate Metabolism
The study included 225 children aged from 14 to 18 years with various manifestations of the metabolic syndrome in neighborhoods, different by iodine provision. The physical development (height, weight, body mass index, w...